Skip to main content

Table 3 Primary and secondary measures

From: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers

Measure

Domain

Scale

Primary measures

 Alternate Uses Test (AUT) [35]

Creativity: divergent thinking

3 items; participants are given the name of a household item and are given 2 min to produce possible uses; responses are marked for fluency (number of responses), flexibility (number of different categories of responses), elaboration (number of elaborative details), and originality (uniqueness of response).

 Big Five Inventory-2 (BFI-2) [50]

Personality: open-mindedness, agreeableness, conscientiousness, extraversion, negative emotionality

60 items on a 5-point scale (1–5) from “disagree strongly” to “agree strongly” with 5 scales reported as the mean response. Open-mindedness scale evaluated as a primary measure and all others as secondary measures.

 Visual Long-Term Potentiation Paradigm (EEG LTP) [55]

Plasticity: Hebbian plasticity

Participants are presented with visual stimuli which is “tetanised” with high-frequency stimulation, assessed as the amplitude of visual-evoked ERP response to tetanised stimuli vs non-tetanised stimuli.

 Roving Mismatch Negativity Paradigm (EEG MMN) [56]

Plasticity: predictive coding

Participants are presented with a series of tones followed by a series of deviant tones, assessed as the amplitude of auditory-evoked ERP response to deviant tone and rate of subsequent habituation to tone.

 Modified Tellegen Absorption Scale (MODTAS) [28, 51]

Personality: absorption

34 items rated on a 5-point scale (0–4) reported as the sum of scores (0–136).

 Remote Associates Task (RAT) [52]

Creativity: convergent thinking

20 items; participants are given 3 words and need to produce a word that all 3 have in common, assessed as number correct and number attempted.

 Resting-State fMRI

Connectivity

9-min continual recording on 3-T Siemens scanner with a 32-channel head coil.

Secondary measures

 5-Dimensional Altered States of Consciousness Questionnaire (5D-ASC) [57, 58]

Drug effects: psychological

91 items rated on VAS (1–100) with 5 scales and 11 subscales reported as % of the maximum score.

 Adverse events

Unwanted health effects

Participants are asked daily to report any “unpleasant health issues” and to rate them as mild, moderate, or serious.

 Consensual Assessment Technique (CAT) [59]

Creativity: non-specific

Participants are given 15 min to complete a paper collage; the result is rated by independent assessors on VAS (0–100) from low to high on (1) creativity and (2) technical goodness, reported as mean rater response.

 Detail and Flexibility Questionnaire (DFlex) [60]

Attention to detail and cognitive rigidity

24 items on a 6-point scale (1–6) with 2 subscales reported as the sum of scores (total 24–144; subscales 12–72).

 Daily questionnaire

Mood: well, sad, happy, stressed, creative, anxious, focused, tired, calm, connected, angry, energy, irritable, motivated, craving

15 items rated on VAS (0–100) reported as individual scores.

 Depression, Anxiety, and Stress Scale (DASS) [61]

Mood: depression, anxiety, stress

42 items on a 4-point scale (0–3) with 3 subscales reported as the sum of scores (0–42).

 Drug Effects Visual Analogue Scale (VAS)

Drug effects: psychological

16 items rated on VAS (0–100) reported as individual and mean scores.

 Electrocardiogram (ECG)

Drug effects: physiological

QT interval, heart rate variability.

 Everyday Problem-Solving Questionnaire

Creativity: problem solving

4 items rated on a VAS (0–100) reported as individual and mean scores.

 Expectancy questionnaire

Expectancy

18 items rated on VAS (0–100; see Table 4).

 Five Facets of Mindfulness Questionnaire (FFMQ) [62]

Mindfulness: observe, act with awareness, non-judgement, describe, non-reacting

39 items rated on a 5-point scale (1–5) with 5 subscales reported as the mean of scores.

 Fitbit Charge 4, Activity and Sleep Tracker, manufactured by Fitbit, San Francisco, CA, USA

Drug effects: physiological

Activity reported as steps per day and sleep reported as minutes asleep per day.

 Genetic biomarkers

Genetic

BDNF Val66Met.

 Inflammatory cytokines

Immune modulation

Plasma concentration of inflammatory cytokines analysed reported in pg/ml.

 NIH Toolbox Picture Vocabulary Test, Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, List Sorting Working Memory Test, Dimensional Change Card Sort Test, Pattern Comparison Processing Speed Test [63]

Cognition: language, attention, executive function, episodic memory, working memory, processing speed

Reported as individual scores and NIH Fluid Cognition Composite Score Uncorrected Standard Score [64].

 NIH Toolbox Anger-Affect, Anger-Hostility, Anger-Physical Aggression, Positive Affect, General Life Satisfaction, Meaning and Purpose, Emotional Support, Instrumental Support, Loneliness, Friendship, Perceived Hostility, Perceived Rejection, Self-Efficacy [65]

Mood: anger, positive affect, general life satisfaction, meaning and purpose, social support, companionship, social distress, self-efficacy

Reported as individual scores and NIH Psychological Well-being Summary, Social Satisfaction Summary [64].

 Pharmacokinetic/pharmacodynamic (PKPD) measures

Drug metabolism

Plasma concentration of drug in pg/ml.

 Peripheral mononuclear blood cell (PMBC) biomarkers

Physiology

5HT2A receptor mRNA expression in PMBC cells.

 Profile of Mood States (POMS) [66]

Mood: fatigue, tension, depression, anger, vigour, confusion

65 items on a 5-point scale (0–4) with 6 subscales reported as the sum of scores.

 Perceived Stress Scale (PSS) [67]

Mood: stress

10 items on a 5-point scale (0–5) reported as the sum of scores.

 Self-Assessment Manikins (SAM) [68]

Drug effects: valence, arousal, dominance

3 items on a 9-point scale (1–9) reported as individual scores.

 Semi-structured audio interview

Open-ended

~ 30-min interview with open-ended questions about the experience of microdosing trial for qualitative analysis.

 Subject release interview

Open-ended

Brief discussion of participant’s experience of first dose and assessment of safety to discharge.

 State of Surrender (SoS) [69]

Mindset: surrender

10 items on a 6-point scale (1–6) reported as the mean of scores.

 State of Preoccupation (SoP) [69]

Mindset: preoccupation

4 items on a 6-point scale (1–6) reported as the mean of scores.

 Vital signs

Physiology

Systolic and diastolic blood pressure in mmHg and heart rate in bpm.